• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病视网膜病变患者血浆中 miR-29b 和 miR-200b 的水平。

Plasma levels of miR-29b and miR-200b in type 2 diabetic retinopathy.

机构信息

Laboratory of Human Molecular Genetics, Universidade Luterana do Brasil (ULBRA), Canoas, RS, Brazil.

Endocrine Division, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.

出版信息

J Cell Mol Med. 2019 Feb;23(2):1280-1287. doi: 10.1111/jcmm.14030. Epub 2018 Nov 23.

DOI:10.1111/jcmm.14030
PMID:30467971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6349208/
Abstract

MicroRNAs (miRNAs/miRs) are involved in the pathogenesis of diabetes mellitus and its chronic complications, and their circulating levels have emerged as potential biomarkers for the development and progression of diabetes. However, few studies have examined the expression of miRNAs in diabetic retinopathy (DR) in humans. This case-control study aimed to investigate whether the plasma levels of miR-29b and miR-200b are associated with DR in 186 South Brazilians with type 2 diabetes (91 without DR, 46 with non-proliferative DR and 49 with proliferative DR). We also included 20 healthy blood donors to determine the miRNA expression in the general population. Plasma levels of miR-29b and miR-200b were quantified by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Proliferative DR was inversely associated with plasma levels of miR-29b (unadjusted OR = 0.694, 95% CI: 0.535-0.900, P = 0.006) and miR-200b (unadjusted OR = 0.797, 95% CI: 0.637-0.997, P = 0.047). However, these associations were lost after controlling for demographic and clinical covariates. In addition, patients with type 2 diabetes had lower miR-200b levels than blood donors. Our findings reinforce the importance of addressing the role of circulating miRNAs, including miR-29 and miR-200b, in DR.

摘要

微小 RNA(miRNAs/miRs)参与糖尿病及其慢性并发症的发病机制,其循环水平已成为糖尿病发展和进展的潜在生物标志物。然而,很少有研究探讨人类糖尿病视网膜病变(DR)中 miRNAs 的表达。本病例对照研究旨在调查 186 名南巴西 2 型糖尿病患者(91 名无 DR、46 名非增殖性 DR 和 49 名增殖性 DR)的血浆 miR-29b 和 miR-200b 水平是否与 DR 相关。我们还纳入了 20 名健康献血者,以确定一般人群中的 miRNA 表达。通过逆转录定量聚合酶链反应(RT-qPCR)定量测定血浆 miR-29b 和 miR-200b 水平。未经调整的 OR 值分别为 0.694(95%CI:0.535-0.900,P=0.006)和 0.797(95%CI:0.637-0.997,P=0.047),提示增殖性 DR 与血浆 miR-29b 和 miR-200b 水平呈负相关。然而,在控制了人口统计学和临床协变量后,这些相关性消失了。此外,2 型糖尿病患者的 miR-200b 水平低于献血者。我们的发现强调了解决循环 miRNAs(包括 miR-29 和 miR-200b)在 DR 中的作用的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c53/6349208/026374df5f01/JCMM-23-1280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c53/6349208/026374df5f01/JCMM-23-1280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c53/6349208/026374df5f01/JCMM-23-1280-g001.jpg

相似文献

1
Plasma levels of miR-29b and miR-200b in type 2 diabetic retinopathy.2 型糖尿病视网膜病变患者血浆中 miR-29b 和 miR-200b 的水平。
J Cell Mol Med. 2019 Feb;23(2):1280-1287. doi: 10.1111/jcmm.14030. Epub 2018 Nov 23.
2
MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy.miR-1281 作为糖尿病视网膜病变患者的新型循环生物标志物。
Front Endocrinol (Lausanne). 2020 Aug 4;11:528. doi: 10.3389/fendo.2020.00528. eCollection 2020.
3
Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.血浆中miR-93的水平与发生2型糖尿病视网膜病变的较高风险相关。
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1159-1166. doi: 10.1007/s00417-017-3638-5. Epub 2017 Apr 5.
4
Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy.循环 miR-3197 和 miR-2116-5p 作为糖尿病视网膜病变的新型生物标志物。
Clin Chim Acta. 2020 Feb;501:147-153. doi: 10.1016/j.cca.2019.10.036. Epub 2019 Oct 31.
5
Effects of miRNA-200b on the development of diabetic retinopathy by targeting gene.微小RNA-200b通过靶向基因对糖尿病视网膜病变发展的影响。
Biosci Rep. 2017 Mar 15;37(2). doi: 10.1042/BSR20160572. Print 2017 Apr 30.
6
Plasma expression: an indicator for the severity of Type 2 diabetes with diabetic retinopathy.血浆表达:2型糖尿病合并糖尿病视网膜病变严重程度的一个指标。
Biosci Rep. 2017 Mar 27;37(2). doi: 10.1042/BSR20160589. Print 2017 Apr 28.
7
Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.血清 miR-20b、miR-17-3p、HOTAIR 和 MALAT1 在糖尿病视网膜病变中的诊断和预后作用。
IUBMB Life. 2019 Mar;71(3):310-320. doi: 10.1002/iub.1970. Epub 2018 Nov 23.
8
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes.与 2 型糖尿病患者视网膜病变相关的血浆 microRNA 特征。
Sci Rep. 2021 Feb 18;11(1):4136. doi: 10.1038/s41598-021-83047-w.
9
MicroRNA Expression in the Aqueous Humor of Patients with Diabetic Macular Edema.糖尿病黄斑水肿患者房水中的 microRNA 表达。
Int J Mol Sci. 2020 Oct 3;21(19):7328. doi: 10.3390/ijms21197328.
10
RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.RNA 测序鉴定出用于糖尿病视网膜病变早期检测的特定循环 miRNA 生物标志物。
Am J Physiol Endocrinol Metab. 2018 Sep 1;315(3):E374-E385. doi: 10.1152/ajpendo.00021.2018. Epub 2018 May 29.

引用本文的文献

1
Circulating microRNAs demonstrate limited diagnostic potential for diabetic retinopathy in the population of Kazakhstan.循环微RNA在哈萨克斯坦人群中对糖尿病视网膜病变的诊断潜力有限。
PeerJ. 2025 Apr 11;13:e19259. doi: 10.7717/peerj.19259. eCollection 2025.
2
The Association of Cell-Free LncH19 and miR-29b Expression with the PI3K/AKT/HIF-1/VEGF Pathway in Patients with Diabetic Nephropathy: In Silico Prediction and Clinical Validation.游离LncH19和miR-29b表达与糖尿病肾病患者PI3K/AKT/HIF-1/VEGF通路的关联:计算机预测与临床验证
Curr Issues Mol Biol. 2024 Dec 31;47(1):20. doi: 10.3390/cimb47010020.
3

本文引用的文献

1
RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.RNA 测序鉴定出用于糖尿病视网膜病变早期检测的特定循环 miRNA 生物标志物。
Am J Physiol Endocrinol Metab. 2018 Sep 1;315(3):E374-E385. doi: 10.1152/ajpendo.00021.2018. Epub 2018 May 29.
2
The Destiny of Glucose from a MicroRNA Perspective.从微小RNA角度看葡萄糖的命运
Front Endocrinol (Lausanne). 2018 Feb 26;9:46. doi: 10.3389/fendo.2018.00046. eCollection 2018.
3
Downregulation of MicroRNA 29a/b exacerbated diabetic retinopathy by impairing the function of Müller cells via Forkhead box protein O4.
12-HETE activates Müller glial cells: The potential role of GPR31 and miR-29.
12-羟基二十碳四烯酸激活 Müller 胶质细胞:GPR31 和 miR-29 的潜在作用
Prostaglandins Other Lipid Mediat. 2024 Apr;171:106805. doi: 10.1016/j.prostaglandins.2023.106805. Epub 2023 Dec 22.
4
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential.糖尿病血脂异常相关的微小囊泡和循环 microRNAs:miR-218、miR-132、miR-143 和 miR-21、miR-122、miR-155 具有生物标志物潜力。
Cardiovasc Diabetol. 2023 Sep 25;22(1):260. doi: 10.1186/s12933-023-01988-0.
5
Effect and mechanism of microRNAs on various diabetic wound local cells.microRNAs 对各种糖尿病创面局部细胞的作用及机制。
J Diabetes. 2023 Nov;15(11):955-967. doi: 10.1111/1753-0407.13474. Epub 2023 Sep 7.
6
Prevalence of diabetic retinopathy in Brazil: a systematic review with meta-analysis.巴西糖尿病视网膜病变的患病率:一项荟萃分析的系统评价
Diabetol Metab Syndr. 2023 Mar 2;15(1):34. doi: 10.1186/s13098-023-01003-2.
7
Diabetic retinopathy: Involved cells, biomarkers, and treatments.糖尿病视网膜病变:受累细胞、生物标志物及治疗方法
Front Pharmacol. 2022 Aug 9;13:953691. doi: 10.3389/fphar.2022.953691. eCollection 2022.
8
The Correlation Between MicroRNAs and Diabetic Retinopathy.miRNAs 与糖尿病视网膜病变的相关性。
Front Immunol. 2022 Jul 25;13:941982. doi: 10.3389/fimmu.2022.941982. eCollection 2022.
9
Dietary Improvement during Lactation Normalizes miR-26a, miR-222 and miR-484 Levels in the Mammary Gland, but Not in Milk, of Diet-Induced Obese Rats.哺乳期饮食改善可使饮食诱导肥胖大鼠乳腺中miR-26a、miR-222和miR-484水平恢复正常,但乳汁中的这些水平未恢复正常。
Biomedicines. 2022 May 31;10(6):1292. doi: 10.3390/biomedicines10061292.
10
Oscillatory Behaviors of microRNA Networks: Emerging Roles in Retinal Development.微小RNA网络的振荡行为:在视网膜发育中的新作用
Front Cell Dev Biol. 2022 Feb 2;10:831750. doi: 10.3389/fcell.2022.831750. eCollection 2022.
微小RNA 29a/b的下调通过叉头框蛋白O4损害米勒细胞的功能,从而加剧糖尿病性视网膜病变。
Diab Vasc Dis Res. 2018 May;15(3):214-222. doi: 10.1177/1479164118756239. Epub 2018 Feb 7.
4
miR-29 contributes to normal endothelial function and can restore it in cardiometabolic disorders.miR-29 有助于维持正常的血管内皮功能,并能在代谢相关心血管疾病中恢复其功能。
EMBO Mol Med. 2018 Mar;10(3). doi: 10.15252/emmm.201708046.
5
Identification of stress-related microRNA biomarkers in type 2 diabetes mellitus: A systematic review and meta-analysis.2型糖尿病中应激相关微小RNA生物标志物的鉴定:一项系统评价和荟萃分析。
J Diabetes. 2020 Sep;12(9):633-644. doi: 10.1111/1753-0407.12643. Epub 2018 Feb 13.
6
Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes.糖尿病血管并发症中表观遗传修饰的新证据。
Front Endocrinol (Lausanne). 2017 Sep 29;8:237. doi: 10.3389/fendo.2017.00237. eCollection 2017.
7
Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy.miRNAs 和长非编码 RNA 在糖尿病视网膜病变进展中的作用。
Biosci Rep. 2017 Nov 29;37(6). doi: 10.1042/BSR20171157. Print 2017 Dec 22.
8
Evaluation of the plasma microRNA levels in stage 3 premature retinopathy with plus disease: preliminary study.评估 3 期早产儿视网膜病变伴 PLUS 病的血浆 microRNA 水平:初步研究。
Eye (Lond). 2018 Feb;32(2):415-420. doi: 10.1038/eye.2017.193. Epub 2017 Sep 29.
9
Protective effect of miR-200b/c by inhibiting vasohibin-2 in human retinal microvascular endothelial cells.miR-200b/c通过抑制血管抑制素-2对人视网膜微血管内皮细胞的保护作用。
Life Sci. 2017 Dec 15;191:245-252. doi: 10.1016/j.lfs.2017.09.001. Epub 2017 Sep 4.
10
Diabetic retinopathy: reversibility of epigenetic modifications and new therapeutic targets.糖尿病视网膜病变:表观遗传修饰的可逆性及新的治疗靶点
Cell Biosci. 2017 Aug 15;7:42. doi: 10.1186/s13578-017-0167-1. eCollection 2017.